Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.
Machado, Fabiana S; Dutra, Walderez O; Esper, Lisia; Gollob, Kenneth J; Teixeira, Mauro M; Factor, Stephen M; Weiss, Louis M; Nagajyothi, Fnu; Tanowitz, Herbert B; Garg, Nisha J.
; 34(6): 753-70, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23076807
Involvement of neutrophils in Chagas disease pathology.
Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection.
Cytokine modulation, oxidative stress and thymic dysfunctions: Role of age-related changes in the experimental Trypanosoma cruzi infection: Age-related thymic dysfunctions and Trypanosoma cruzi infection.
Experimental evidences that P21 protein controls Trypanosoma cruzi replication and modulates the pathogenesis of infection.
Molecular mechanisms of myocarditis caused by Trypanosoma cruzi.
Trypanosoma cruzi: biotherapy made from trypomastigote modulates the inflammatory response.
Subverting bradykinin-evoked inflammation by co-opting the contact system: lessons from survival strategies of Trypanosoma cruzi.
Infection by Trypanosoma cruzi in the central nervous system in non-human mammals: a systematic review.
Cardiac damage induced by immunization with heat-killed Trypanosoma cruzi is not antibody mediated.
A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.